Evidence map›Paper›PMID 29383098›Full record

ArticleOncotarget2017

CAPE-

Xiaoling Wang, Dejuan Li, Lu Fan, Qianhan Xiao, Hua Zuo, Zhubo Li

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Effect ofAnalytical cellular pathology (Amsterdam) · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. CAPE-Frontiers in oncology · 2019
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xiaoling WangCollege of Pharmaceutical Sciences, Southwest University, Chongqing 400716, China.
Dejuan LiCollege of Pharmaceutical Sciences, Southwest University, Chongqing 400716, China.
Lu FanCollege of Pharmaceutical Sciences, Southwest University, Chongqing 400716, China.
Qianhan XiaoCollege of Pharmaceutical Sciences, Southwest University, Chongqing 400716, China.
Hua ZuoCollege of Pharmaceutical Sciences, Southwest University, Chongqing 400716, China.
Zhubo LiCollege of Pharmaceutical Sciences, Southwest University, Chongqing 400716, China.
Southwest University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic nephropathy (DN) is one of the most severe complications of diabetes mellitus. This study aimed to determine the effects and potential mechanism of caffeic acid para-nitro phenethyl ester (CAPE-

Indexed as

Akt/NF-κB/ iNOS pathwaycaffeic acid p-nitro phenethyl ester (CAPE-pNO2)diabetic nephropathy (DN)glomerular mesangial cells (GMCs)

Identifiers

PMID29383098
PMCPMC5777710
OpenAlexW2771758044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.